IGI Logo

Torrent Pharmaceuticals is currently trading at Rs. 3377.45, up by 41.20 points or 1.23% from its previous closing of Rs. 3336.25 on the BSE.

The scrip opened at Rs. 3336.40 and has touched a high and low of Rs. 3388.00 and Rs. 3330.45 respectively. So far 3622 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3589.95 on 10-Oct-2024 and a 52 week low of Rs. 2798.25 on 04-Jul-2024.

Last one week high and low of the scrip stood at Rs. 3482.95 and Rs. 3289.55 respectively. The current market cap of the company is Rs. 113737.97 crore.

The promoters holding in the company stood at 68.31%, while Institutions and Non-Institutions held 24.66% and 7.03% respectively.

Torrent Pharmaceuticals has executed share purchase agreement (SPA) with employees of the J.B. Chemicals & Pharmaceuticals for acquisition of up to 38,75,056 equity shares, representing 2.41% equity share capital of the J.B. Chemicals & Pharmaceuticals on a fully diluted basis, for a cash consideration, at a price of Rs 1,600 per equity share aggregating to a total consideration of around Rs 620 crore. Further, the company may acquire the balance equity shares forming part of the Potential Acquisition i.e., up to 6,24,726 equity shares, representing 0.39% of the equity share capital of the J.B. Chemicals & Pharmaceuticals, on a fully diluted basis, from certain other employees of the J.B. Chemicals & Pharmaceuticals, at a price not exceeding Rs 1,600 per equity share.

Earlier, the company’s board had approved the acquisition of up to 44,99,782 equity shares, representing up to 2.80% of the equity share capital of the J.B. Chemicals & Pharmaceuticals on a fully diluted basis, from certain employees.

Torrent Pharmaceuticals (Torrent Pharma) is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.